Published in Can J Physiol Pharmacol on December 21, 2011
Total Serum Fatty Acid Analysis by GC-MS: Assay Validation and Serum Sample Stability. Curr Pharm Anal (2013) 1.04
Adverse effects of ethyl esters or oxidation products in omega-3 preparations? Cardiovasc J Afr (2014) 0.76
Intake of n-3 Polyunsaturated Fatty Acids Increases Omega-3 Index in Aged Male and Female Spontaneously Hypertensive Rats. ISRN Nutr (2013) 0.75
Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure. Redox Biol (2013) 0.75
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Athlete's heart or hypertrophic cardiomyopathy? Clin Res Cardiol (2008) 2.32
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem (2004) 2.23
Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2005) 2.11
Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol (2012) 2.05
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2011) 1.63
Method for aortic wall strain measurement with three-dimensional ultrasound speckle tracking and fitted finite element analysis. Ann Thorac Surg (2013) 1.56
Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology. Am Heart J (2006) 1.55
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol (2002) 1.53
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation (2003) 1.47
Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab (2003) 1.46
Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology (2007) 1.42
Non-compaction cardiomyopathy in an adult with hereditary spherocytosis. Eur J Heart Fail (2006) 1.41
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39
Accuracy of cardiac magnetic resonance imaging modalities to diagnose myocarditis. Eur J Heart Fail (2011) 1.38
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab (2004) 1.35
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol (2008) 1.12
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz (2006) 1.11
Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs (2005) 1.10
Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest (2005) 1.09
Late gadolinium enhancement in sarcoidosis: ventricular wall stress should not be overlooked. Chest (2015) 1.07
Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab (2004) 1.02
Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol (2003) 0.99
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol (2011) 0.98
Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol (2002) 0.98
Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol (2006) 0.97
Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function. Biochem Biophys Res Commun (2005) 0.96
Management strategies in pericardial emergencies. Herz (2006) 0.96
Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging. Herz (2005) 0.95
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab (2008) 0.95
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz (2002) 0.94
Whole-body vibration therapy in intensive care patients: A feasibility and safety study. J Rehabil Med (2016) 0.94
Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev (2013) 0.93
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol (2012) 0.93
Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation (2004) 0.93
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92
Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun (2004) 0.91
Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J Periodontol (2007) 0.90
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol (2003) 0.90
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. Kardiol Pol (2015) 0.89
Sudden cardiac death in dilated cardiomyopathy -- therapeutic options. Herz (2002) 0.89
Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. Int J Cardiol (2011) 0.89
Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Pacing Clin Electrophysiol (2006) 0.89
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet (2012) 0.88
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev (2013) 0.88
Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. Cardiovasc Pathol (2007) 0.88
Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol (2003) 0.87
N-3 polyunsaturated fatty acids and statins in heart failure. Lancet (2009) 0.86
Molecular mechanisms involved in atherosclerosis. Herz (2002) 0.86
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent. J Cell Biochem (2007) 0.86
Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J (2005) 0.86
Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria. Apoptosis (2008) 0.86
Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol (2006) 0.86
Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol (2002) 0.86
[On guidelines for the treatment management]. Herz (2006) 0.85
[Guidelines -- substitute textbook guidelines for daily or limited use?]. Herz (2009) 0.85
Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion. Heart Fail Rev (2013) 0.85
Cytokines in pericardial effusion of patients with inflammatory pericardial disease. Mediators Inflamm (2012) 0.85
Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res (2007) 0.85
Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy. J Med Virol (2011) 0.85
Dilated cardiomyopathies as a cause of congestive heart failure. Herz (2002) 0.84
Occurrence of late gadolinium enhancement in ventricular ballooning or Tako-Tsubo syndrome: increased wall stress should not be overlooked. Eur Heart J (2009) 0.84
[Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers]. Herz (2009) 0.84
Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (2005) 0.84
Biomarkers in inflammatory and noninflammatory cardiomyopathy. Herz (2009) 0.83
Late gadolinium enhancement and higher risk of arrhythmias: fibrosis or increased ventricular wall stress? J Am Coll Cardiol (2011) 0.83
The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels. J Clin Endocrinol Metab (2005) 0.83
Inflammation in dilated cardiomyopathy. Herz (2004) 0.83
Pathophysiology of cardiac inflammation: molecular mechanisms. Herz (2002) 0.82
Replacement of reduced highly unsaturated fatty acids (HUFA deficiency) in dilative heart failure: dosage of EPA/DHA and variability of adverse peroxides and aldehydes in dietary supplement fish oils. Cardiology (2013) 0.82
Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy. Curr Treat Options Cardiovasc Med (2007) 0.82
Genetics of human hypertension. Herz (2003) 0.82
Management of pericardial effusion the role of echocardiography in establishing the indications and the selection of the approach for drainage. Herz (2005) 0.81
Evaluation of the presence of selected viral and bacterial nucleic acids in pericardial samples from dogs with or without idiopathic pericardial effusion. Vet J (2007) 0.81
Lipids and lipoproteins in women. Herz (2005) 0.81
Heart rate turbulence following ventricular premature beats in healthy controls. Ann Noninvasive Electrocardiol (2003) 0.81
[Excessive hyperchylomicronemia--a rare cause of acute retrosternal and epigastric pain in pregnancy]. Herz (2003) 0.81
Plasmodium falciparum glycosylphosphatidylinositol induces limited apoptosis in liver and spleen mouse tissue. Apoptosis (2007) 0.81
Detection of anti-hsp70 immunoglobulin G antibodies indicates better outcome in coronary artery bypass grafting patients suffering from severe preoperative angina. Ann Thorac Surg (2004) 0.80
A new but frequent mutation of apoB-100-apoB His3543Tyr. Atherosclerosis (2004) 0.80
Cardiac sarcoidosis: cytokine patterns in the course of the disease. Arch Pathol Lab Med (2003) 0.80
Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart. Clin Chem Lab Med (2010) 0.80
Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy. Eur J Hum Genet (2010) 0.80